Vol. 3 No. 4 (2025): FIB-4 ≥1.3 is correlated with increased DKD risk in T2D, but SGLT2i therapy that lowers FIB-4 attenuates this
Published:
2025-12-15
For all queries related to submissions, editorial matters, journal policies, and membership for Diabzen—the official journal of the Cardiabcon Society—please use the following contact information:
Editorial and Administrative Correspondence
Mailing Address:
36/44 FK Kabir Nagar, Shakti Nagar, Durgakund, Varanasi – 221010, India
Phone:
+91-9901206308 / +91 87958 32853
Email:
cardiabconsociety@gmail.com
Website:
www.cardiabcon.com
